Global Response to the COVID-19 Outbreak Intensifies
Co-Diagnostics, Inc. (CODX)
US:NASDAQ Investor Relations:
ir.codiagnostics.com/investor-relations
Company Research
Source: PR Newswire
NEW YORK, March 12, 2020 /PRNewswire/ -- The coronavirus (COVID-19) outbreak continues to spread around the world. According to the World Health Organization (WHO), the number of confirmed cases crossed the 100,000 mark over the weekend and cases have been reported from over 100 countries. The death toll from COVID-19 passed 4,000 worldwide. WHO now indicates that the fact that so many have been affected so quickly is troubling and that the threat of a pandemic is very real. In the meantime, the United States and Europe continued to accelerate their response to the outbreak, preparing for a probable increase of COVID-19 cases. Italy, which in an unprecedented move has extended its containment measures to the entire country, has confirmed more than 9,000 cases. As for the U.S, an effort has been made to contain the spread of the virus by restricting travel to and from China and isolating identified cases. Plus, several biotechnology companies announced publicly that they began work on
Show less
Read more
Impact Snapshot
Event Time:
CODX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CODX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CODX alerts
High impacting Co-Diagnostics, Inc. news events
Weekly update
A roundup of the hottest topics
CODX
News
- Global COVID-19 Diagnostic Market Report 2024 -2029: A New Very Large and Sustainable Market for Covid Related Diagnostics is Emerging [Yahoo! Finance]Yahoo! Finance
- Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility [Yahoo! Finance]Yahoo! Finance
- Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo FacilityPR Newswire
- Co-Diagnostics, Inc. (NASDAQ: CODX) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $1.50 price target on the stock.MarketBeat
- Co-Diagnostics Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]Yahoo! Finance
CODX
Earnings
- 11/7/24 - Beat
CODX
Analyst Actions
- 11/11/24 - HC Wainwright
CODX
Sec Filings
- 11/25/24 - Form 4
- 11/25/24 - Form 4
- 11/25/24 - Form 4
- CODX's page on the SEC website